Additionally, B-PMO has also been used for research in canine models of DMD that better mimic the pathophysiology of human illness and serve as a more rigorous evaluation of the efficacy of CPP-PMOs in restoring dystrophin expression. This evidence concerns the gene DMD and Duchenne muscular dystrophy.